Hydromorphone (Dilaudid)

Category:

  • Analgesic

Description:

  • Semisynthetic opiate agonist analgesic

Indications:

  • Moderate to severe pain

  • Cough suppressant

Contraindications:

  • Patients with impaired respiratory function.

Precautions:

  • Pregnancy Category C

  • Patients will experience CNS effects of drowsiness and dizziness, therefore use caution with motor vehicle operation or other hazardous tasks.

  • Avoid prolonged, sustained usage to decrease addiction potential.

  • Use with caution with other CNS depressive medications.  

  • Like any narcotic, may be addictive when used for prolonged periods of time (weeks to months).

  • Pregnancy Category

Adverse Reactions (Side Effects):

  • Sedation

  • Dizziness  

Dosage:

Administered in smallest effective dose and as infrequently as possible

Administered orally, rectally, SQ, IM or slow IV push

Adult:

  • Normal: 2mg q4-6h as needed

  • Severe pain/terminally-ill: 4mg (oral), 2mg (IM) or 3-4mg (IV) q3-6h as needed or tolerated

  • Rectally: 3mg q6-8h as needed

Cough suppressant:

  • Adults and children greater than 12 years old 1mg (oral) q3-4h

  • Children 6-12 years old: 0.5 mg (oral) q3-4h

 

 

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300  

Gynecology and Obstetrics CD-ROM
Volumes 1-6
2004 Edition
Lippincott Williams & Wilkins
Copyright 2004
All Rights Reserved